Considerations for the use of anthelminthic therapy for the treatment of neurocysticercosis
Taysha Gene Therapies Inc 2024年度报告
AK112 to validate its potential as next-generation IO therapy
Intra-Cellular Therapies Inc 2024年度报告
BioRestorative Therapies Inc 2024年度报告
Medical Rationale Supporting Patient Access To Novel Oncology Combination Therapies